HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?

AuthorsIrene Cañamares-Orbis, José Tiago Silva, Francisco López-Medrano, Jose Maria Aguado
JournalEnfermedades infecciosas y microbiologia clinica (Enferm Infecc Microbiol Clin) Vol. 33 Issue 4 Pg. 294 (Apr 2015) ISSN: 1578-1852 [Electronic] Spain
PMID25444038 (Publication Type: Letter)
Chemical References
  • Anti-Bacterial Agents
  • Fosfomycin
  • Sodium
  • Daptomycin
Topics
  • Aged, 80 and over
  • Anti-Bacterial Agents (administration & dosage, adverse effects, therapeutic use)
  • Aortic Valve Insufficiency (etiology)
  • Atrial Fibrillation (complications)
  • Daptomycin (therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Dyspnea (etiology)
  • Endocarditis, Bacterial (complications, drug therapy)
  • Female
  • Fosfomycin (administration & dosage, adverse effects, therapeutic use)
  • Heart Failure (chemically induced)
  • Hepatitis C, Chronic (complications)
  • Humans
  • Prosthesis-Related Infections (drug therapy)
  • Sodium (administration & dosage, adverse effects)
  • Staphylococcal Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: